Placebo Cannabidiol

DRUG2 trials

Sponsors

Central Institute of Mental Health, Mannheim, Hannah Harris

Conditions

Abuse LiabilityCannabisExperimental Pain in Healthy Human ParticipantsSchizophrenia

Early Phase 1

Repeated CBD Administration and Cannabis Outcomes

RecruitingNCT07434895

Hannah HarrisAbuse Liability, Cannabis, Experimental Pain in Healthy Human Participants

Start: 2026-08-05End: 2029-12-01Target: 23Updated: 2026-08-12

Phase 2

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

TerminatedNCT02088060

Central Institute of Mental Health, MannheimSchizophrenia

Start: 2015-12-08End: 2024-09-16Target: 150Updated: 2024-12-27